Volpara Health Technologies is raising up to $17 million via a placement through Morgans and Bell Potter.
The offer for the company, which provides digital technology to detect breast cancer, will comprise an institutional placement to raise $15 million and a non-underwritten share purchase plan of up to $3 million.
The offer price is at 60c per share, which is a 13 per cent discount to the last traded price on Tuesday of 69c.
The proceeds are being used to accelerate Volpara’s growth in the United States and “own” the market based on opportunities already in the pipeline, according to a term sheet sent to investors.